pharmaceutical daily

October 17, 2019 Off

Cytel to hold Complex Innovative Trial Design symposium

Cytel Inc., the leading global provider of innovative analytical software and consulting services to the life sciences industry, has announced its Complex Innovative Trial Design Symposium and East Training event, which will bring together industry-leading experts to discuss innovative solutions to pressing challenges including rare disease clinical trials, and will also offer delegates an in-depth East software training session.

October 17, 2019 Off

FDA reviews Foamix’s NDA for minocycline topical foam for Rosacea

By Dino Mustafić

The FDA has accepted for review Foamix’s New Drug Application (NDA) for FMX103 (minocycline topical foam 1.5%) topical foam, for the treatment of moderate-to-severe papulopustular rosacea in adults.

October 17, 2019 Off

UN closer to reach goal of treating 40 million people for TB in five years

By Dino Mustafić

The UN Political Declaration has for a goal to treat 40 million people for TB disease in the 5-year period 2018-22, and 7 million have already been treated in 2018.

October 17, 2019 Off

Lysogene names Stéphane Durant des Aulnois as Chief Financial Officer

By BusinessWire

Lysogene has named Stéphane Durant des Aulnois, from Ipsen, as new Chief Financial Officar, who will also be a member…

October 17, 2019 Off

Genentech gets FDA approval of Xofluza for risk of developing influenza-related complications

By BusinessWire

Genentech has received FDA’s approval of Xofluza, which is the first and only antiviral medicine indicated specifically for patients at…

October 17, 2019 Off

Acerus’ study shows Natesto significantly increases mean testosterone levels

By BusinessWire

Acerus Pharmaceuticals said Thursday in a press release that new data showed that Natesto increases serum testosterone and improves symptoms…

October 17, 2019 Off

Teneobio, Selexis move to three license deals for multi-specific oncology antibody candidates

By BusinessWire

GENEVA & NEWARK, Calif.–(BUSINESS WIRE)–Selexis SA and Teneobio, Inc. announced today that they have signed three commercial license agreements (CLAs)…

October 17, 2019 Off

NeuClone starts dosing Stelara biosimilar candidate, NeuLara, in a Phase I clinical trial

By BusinessWire

NeuClone starts dosing NeuLara ustekinumab the first patients, a Johnson and Johnson’s Stelara biosimilar candidate, in a Phase I clinical…

October 17, 2019 Off

Cadent Therapeutics displays its lead asset’s testing progress, with new medical boss named

By BusinessWire

Cadent Therapeutics has named Dawn Wilson appointed as Vice President, Clinical Operations, as it releases the data from Phase 2…

October 17, 2019 Off

Inversago Pharma adds to its Board of Directors

By BusinessWire

Inversago has welcomed Dennis Kim, MD, MBA and Tara Nickerson, PhD, MBA as new independent directors, following its goal to…